Table 1.
Summary of the protocols and datasets used.
| Sample name (cell line) | Protocol 1 | Protocol 2 | Protocol 3 | Treatment | Data |
|---|---|---|---|---|---|
| MCF7 (CTRL)_1 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | — | PRIDE PXD012630 |
| MCF7 (CTRL)_2 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | — | PRIDE PXD012630 |
| MCF7 (CTRL)_3 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | — | PRIDE PXD012630 |
| Ct-ERα (sample)_1 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | — | PRIDE PXD012630 |
| Ct-ERα (sample)_2 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | — | PRIDE PXD012630 |
| Ct-ERα (sample)_3 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | — | PRIDE PXD012630 |
| Ct-ERα (sample)_1 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | RNase A | PRIDE PXD012630 |
| Ct-ERα (sample)_2 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | RNase A | PRIDE PXD012630 |
| Ct-ERα (sample)_3 | Nuclear protein extracts | Tandem Affinity Purification | Nano LC-MS/MS | RNase A | PRIDE PXD012630 |